Praxis receives FDA alignment on ulixacaltamide NDA submission plans

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. QCOM
5. IONS
6. AZN
7. ROIV
8. AAPL
9. HOOD
10. QQQ

Go back to Praxis receives FDA alignment on ulixacaltamide NDA submission plans
(NASDAQ: PRAX) Delayed: 352.48 +0.67 (0.19%)
Previous Close $351.81    52 Week High $ 
Open $342.25    52 Week Low $ 
Day High $356.29    P/E N/A 
Day Low $339.50    EPS $ 
Volume 252,618